Scholars Central

Conference abstract

Validation of a new high throughput in vitro Luciferase based assay to identify fast acting antimalarial compounds

Authors: Yi Hua Katherine Chan

Ask about this article

Abstract

Select any words in the title or abstract, or press this and choose a sentence.

Aim: To validate a new high throughput in vitro Luciferase based assay to identify fast acting antimalarial compounds. Rational: In partnership with Medicines for Malaria Venture, Novartis Institute for Tropical Diseases (NITD) research efforts focused on finding new drugs with diverse modes of action to combat resistance, block transmission, prevent infection, and reduce relapse. One approach in antimalarial drug development is to identify novel chemical lead series for fast acting, blood stage anti-malarial with novel mode of action, which will potentially lead to rapid parasite reduction and fever clearance in patients. Approach: Leveraging the Cas9 technology, we integrated a luciferase reporter gene under the control of the Plasmodium calmodulin promoter into a non-essential locus (Elo1). Using this luciferase expressing parasites line (3D7), we developed a robust in vitro assay to evaluate the inhibitory effect of a compound on the growth of ring-stage malarial parasite at 6 hour, thus enabling distinction of fast from slow acting compounds in vitro. Assay was validated with marketed anti-malarial compounds and further miniaturized to 384-well microplates, so as to facilitate high throughput screening, where 4000 compounds from Novartis collection were screened in dose response format. Conclusion: Promising novel scaffolds were identified and are currently being profiled. The readout of the assay allowed us to rank compounds according to their in vitro activity and the classification of fast versus slow correlated well with available in vivo data. Incorporation of this new high throughput robust assay in phenotypic screening allowed prioritization and evaluation of compounds, as well as an opportunity to gain insights into the possible mode of action of the compound.

Ask about this article

Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.

Try:

Follow

New articles from what you follow go into your email digest, once you agree to alert emails.

  • JournalJournal of Tropical Diseases & Public Health
  • SubjectInfectious Diseases
  • SubjectPublic Health & Epidemiology
  • BylineArticles whose byline prints “Yi Hua Katherine Chan”